Compounded Ozempic and Wegovy, cheaper generic versions of the weight-loss drugs, can no longer be sold. Doctor explains ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Doctors and patients have been hoping for a pill version that would be easier to take, in contrast to an injectable.

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

A new oral weight-loss ... injections. The company plans to seek regulatory approval for the pill as an obesity treatment by the end of 2025, followed by a diabetes indication in 2026. Injectable ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, Wegovy, Mounjaro and Zepbound, a clinical trial shows.

This star posed a very shocking image to Instagram on Sunday. The mother of one - who got her start in stand-up comedy - has ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...